| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 04/06/2006 | US20060073567 Novel insulin/IGF/relaxin family polypeptides and DNAs thereof |
| 04/06/2006 | US20060073566 Active modified hedgehog proteins |
| 04/06/2006 | US20060073162 Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor |
| 04/06/2006 | DE10231370B4 Thiophenglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel Thiophenglycosidderivate, pharmaceutical compositions containing them and methods for making these drugs |
| 04/06/2006 | CA2581922A1 1-(.beta.-d-glycopyranosyl)-3-substituted nitrogenous heterocyclic compound, medicinal composition containing the same, and medicinal use thereof |
| 04/06/2006 | CA2581665A1 Osteogenic oligonucleotides and uses thereof |
| 04/05/2006 | EP1642975A2 Chemokine receptors 88-2B (CKR-3) and their antibodies |
| 04/05/2006 | EP1642974A1 Recombinant soluble Fc receptors |
| 04/05/2006 | EP1642973A1 Therapeutic uses of BR43X2 soluble receptors |
| 04/05/2006 | EP1642972A1 Therapeutic uses of BR43X2 soluble receptors |
| 04/05/2006 | EP1642898A1 Heteroaryloxy nitrogenous saturated heterocyclic derivative |
| 04/05/2006 | EP1642596A2 Treatment of autoimmune diseases with antagonists which bind to B cell surface markers |
| 04/05/2006 | EP1642585A1 Osteogenic oligonucleotides and uses thereof |
| 04/05/2006 | EP1642574A2 Combination of a beta-2 adrenoceptor agonist and an aminosugar and their use for the treatment of immunomodulatory disorders |
| 04/05/2006 | EP1641824A1 Relaxin superfamily peptide analogues |
| 04/05/2006 | EP1641535A2 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 04/05/2006 | EP1641467A1 (20s)-1alpha-hydroxy-2-methylene-19-nor-vitamin d3 and its uses |
| 04/05/2006 | EP1641466A1 2-methylene-19-nor-20(s)-25-methyl-1alpha-hydroxycalciferol and its uses |
| 04/05/2006 | EP1453777B1 Functionalized higher diamondoids |
| 04/05/2006 | EP1438104B1 Co-cycloalkyl 17-heteroaryl prostaglandin e2 analogs as ep2-receptor agonists |
| 04/05/2006 | EP1383522B1 A medicament or a dressing containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use in the treatment of inflammatory skin conditions |
| 04/05/2006 | EP1280524B1 Methods and compositions for modulating alpha adrenergic receptor activity |
| 04/05/2006 | EP1198235A4 Method of promoting bone growth with hyaluronic acid and growth factors |
| 04/05/2006 | EP1173427B1 Hydroxamic acid derivative |
| 04/05/2006 | EP1147413B1 Growth differentiation factor inhibitors and uses therefor |
| 04/05/2006 | EP1086098B1 Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists |
| 04/05/2006 | EP0991660B8 DEUTERATED and undeuterated CYCLOSPORINE ANALOGS AND THEIR USE AS IMMUNOMODULATING AGENTS |
| 04/05/2006 | EP0981514B1 3-epi vitamin d2 compounds and uses thereof |
| 04/05/2006 | EP0800397B1 Bone mass anabolic composition comprising olpadronate |
| 04/05/2006 | CN1756753A Benzofuran derivative |
| 04/05/2006 | CN1756546A Microglia inhibitors for interrupting interleukin 12 and ifn-gamma-mediated immune reactions |
| 04/05/2006 | CN1756540A Use of non-immunosuppressant 2-nipecoti acid derivative in inducing chondrosis and differentiation |
| 04/05/2006 | CN1754880A Process for preparing 2-iminopyrrolidine derivatives |
| 04/05/2006 | CN1754878A Strontium ranelate alpha crystalline form, method for the preparation thereof and pharmaceutical compositions containing said agent |
| 04/05/2006 | CN1754567A Rheumatism arthritis therapeutic plaster and its preparation process |
| 04/05/2006 | CN1754566A Oral capsule and plaster for treating femoral head ischemic necrosis, and its preparation method |
| 04/05/2006 | CN1754563A Hyperosteogeny plaster |
| 04/05/2006 | CN1754553A Use of erythrina and its isoflavone analog compound in medicine for osteoporosis |
| 04/05/2006 | CN1249087C Novel human G-Protein coupled receptor |
| 04/05/2006 | CN1249074C 2-aminocarbonyl-9H-punine derivatives |
| 04/05/2006 | CN1249066C 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
| 04/05/2006 | CN1249063C Immunoregulatory compounds |
| 04/05/2006 | CN1249059C Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same |
| 04/05/2006 | CN1249039C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type I |
| 04/05/2006 | CN1249033C Cyclic amp-specific phosphodiesterase inhibitors |
| 04/05/2006 | CN1249025C Aminobenzophenones as inhibiotors of IL-1 beta and TNF-alpha |
| 04/05/2006 | CN1248744C Medicinal thread for hyperosteogeny and application thereof |
| 04/05/2006 | CN1248727C Capsule for treating rheumatism and its manufacturing method |
| 04/05/2006 | CN1248723C Medicinal liquor for rheumatism and preparation method thereof |
| 04/05/2006 | CN1248707C Bone-setting medicine |
| 04/05/2006 | CN1248706C Pillworm application in preparation of medicine to treat osteoproliferation |
| 04/05/2006 | CN1248693C Sustained release formulation of glucosamine salt and preparation |
| 04/04/2006 | US7022870 Antidepressants; sexual disorders; anticancer agnets; hormone replacement therapy |
| 04/04/2006 | US7022856 Carboline derivatives |
| 04/04/2006 | US7022849 Quinazoline and pyrido[2,3-d]pyrimidine inhibitors of phosphodiesterase (PDE) 7 |
| 04/04/2006 | US7022818 of given amino acid sequence; use as a target for drug screening of antagonists or agonists of said receptor; receptor can bind persephin |
| 04/04/2006 | US7022738 (3S)-N-butyl-3-((2S)-2-(((4-fluorophenyl)sulfonyl)amino)-3-methylbutanoylamino)-5-methyl-2-oxohexanamide; calpain inhibition; Alzheimer's, osteoporosis, brain and eye disorders, ischemia |
| 04/04/2006 | US7022717 Chemokine receptor binding heterocyclic compounds |
| 04/04/2006 | US7022715 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 04/04/2006 | US7022711 2-(4-Pyridyl)amino-6-dialkoxyphenyl-pyrido[2,3-d]pyrimidin-7-ones |
| 04/04/2006 | US7022690 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
| 04/04/2006 | US7022500 Humanized immunoglobulins |
| 04/04/2006 | US7022485 immunogens or target antigens comprising citrullinated polypeptide derived from fragments of fibrinogen; prophylaxis of inflammatory disorders |
| 04/04/2006 | CA2256492C Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists |
| 03/30/2006 | WO2006002976A3 Canine osteoarthritis diet formulation |
| 03/30/2006 | WO2003014294A3 Tacis and br3 polypeptides and uses thereof |
| 03/30/2006 | US20060069246 Tumor necrosis factor receptor related proteins Tango-63d and Tango-63e |
| 03/30/2006 | US20060069242 Neurotrophic factor receptor |
| 03/30/2006 | US20060069131 Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
| 03/30/2006 | US20060069130 Novel crystals |
| 03/30/2006 | US20060069129 Chemokine receptor binding heterocyclic compounds |
| 03/30/2006 | US20060069126 Pharmaceutically active isoindoline derivatives |
| 03/30/2006 | US20060069120 Novel piperidine derivaties as modulators of chemokine receptor ccr5 |
| 03/30/2006 | US20060069098 Bone disorders; reduce concentration of parathyroid hormone in blood |
| 03/30/2006 | US20060069084 Methods of inhibiting kinases |
| 03/30/2006 | US20060069067 Combination of an aromatase inhibitor with a bisphosphonate |
| 03/30/2006 | US20060069062 toothpastes, mouthwashes, chewing gums, tableted candy, for inhibiting induction of dental caries |
| 03/30/2006 | US20060069037 Peptide-containing alpha-ketoamide cysteine and serine protease inhibitors |
| 03/30/2006 | US20060069028 A carbamate or urea containing comopound is useful to treat angiogeneisis; methionine aminopeptidase 2 (MetAP-2) coupled to a peptide prevents the metabolic degradation of the angiogenesis inhibitor compound |
| 03/30/2006 | US20060068036 Extract of Dioscorea sp. and the medical uses thereof |
| 03/30/2006 | US20060068027 Methods for regulating levels of zinc, cadmium and calcium in humans and for diagnosing, or screening for the risk of developing, diseases associated with abnormal levels of cadmium, zinc and calcium in body fluids and tissues |
| 03/30/2006 | US20060067938 Methods for the treatment of osteoarthritis and compositions thereof |
| 03/30/2006 | US20060067932 Antagonists specific for denatured collagen and methods of using same |
| 03/30/2006 | DE202006000591U1 Composition useful for providing nutrients to healthy joints, comprises glucosamine, chondroitin, copper salt, selenium salt in rapid-release form and vitamins C, E, B6 and B12, folic acid, zinc salt, manganese salt in delayed-release form |
| 03/30/2006 | DE102004046530A1 New bicyclic imidazole derivatives are dipeptidylpeptidase-IV inhibitors useful to treat e.g. arthritis, obesity, allograft transplantation and calcitonin-induced osteoporosis |
| 03/30/2006 | DE102004043944A1 Neue 8-(3-Amino-piperidin-1-yl)-7-(but-2-inyl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel New 8- (3-amino-piperidin-1-yl) -xanthines -7- (but-2-ynyl), their preparation and their use as medicaments |
| 03/30/2006 | CA2797769A1 Peptides and apl-type derivatives of hsp60 and pharmaceutical compositions |
| 03/30/2006 | CA2580881A1 Use of microproteins as tryptase inhibitors |
| 03/30/2006 | CA2579406A1 6-(2-alkyl-phenyl) - pyrido[2,3-d] pyrimidines useful as protein kinase inhibitors |
| 03/29/2006 | EP1640898A1 Medical care self-cell delivery support system, medical care self-cell delivery support financial system, and their methods |
| 03/29/2006 | EP1640449A1 Cell differentiation inhibiting agent, cell culture method using the same, culture medium and cultured cell line |
| 03/29/2006 | EP1640010A1 Agent inducing increase in bone mass |
| 03/29/2006 | EP1638979A1 Thienopyridone derivatives as kinase inhibitors |
| 03/29/2006 | EP1638948A1 Diphenylurea derivatives and their use as chloride channel blockers |
| 03/29/2006 | EP1638603A1 Methods for the prevention and treatment of diseases caused by an inflammatory response mediated by endogenous substance p by using anti-substance p antibodies |
| 03/29/2006 | EP1638591A1 Class iii slrp agonists for the reduction of blood vessel formation |
| 03/29/2006 | EP1638555A1 Substituted 5-membered ring compounds and their use |
| 03/29/2006 | EP1638552A2 Use of (3.2.0) heterocyclic compounds and analogs thereof for the treatment of cancer, inflammation and infectious diseases |
| 03/29/2006 | EP1638544A2 Ketones and reduced ketones as therapeutic agents for the treatment of bone conditions |
| 03/29/2006 | EP1467998B1 Tetracyclic heterocompounds as estrogen receptor modulators |